Press Releases Generation Bio Co.

Equities

GBIO

US37148K1007

Delayed Nasdaq Other stock markets 09:30:00 2024-06-05 am EDT			5-day change	1st Jan Change
3.16 ^USD	+1.28%		+3.61%	+91.52%

May. 13	Generation Bio Co. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 09	Generation Bio Co. Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms At the ASGCT 27th Annual Meeting	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results	May. 13	GL
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting	May. 09	GL
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting	Apr. 22	GL
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference	Apr. 02	GL
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results	Mar. 06	GL
Generation Bio to Present at the 2024 TD Cowen Health Care Conference	Feb. 27	GL
Generation Bio to Present at the 2024 TD Cowen Health Care Conference	Feb. 27	AQ
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference	Jan. 03	GL
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms	Nov. 29	GL
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms	Nov. 29	AQ
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results	Nov. 09	GL
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform	23-10-26	GL
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform	23-10-26	AQ
Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA	23-10-18	GL
Phenylketonuria Pipeline, Emerging Drugs, Clinical Trials, and FDA Approvals 2023 (Updated)	23-09-28	AQ
Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit	23-09-19	GL
Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference	23-08-03	GL
Generation Bio Reports Second Quarter 2023 Financial Results	23-08-02	GL
GENERATION BIO CO. : Submission of Matters to a Vote of Security Holders (form 8-K)	23-06-09	AQ
Generation Bio to Present at the 2023 Jefferies Healthcare Conference	23-05-31	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Generation Bio Co.

Equities

GBIO

US37148K1007

Press Releases

Filters